Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$CTKB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the midpoint by $1 million total.

Price since post

Full Details

Advertisement|Remove ads.